Inactive/Delisted stock
PainReform Stock (NASDAQ:PRFX)
Previous Close
$2.37
52W Range
$0.43 - $16.63
50D Avg
$1.51
200D Avg
$2.31
Market Cap
$3.70M
Avg Vol (3M)
$2.90M
Beta
0.57
Div Yield
-
PRFX Company Profile
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.